ReviewFrontiers in oncology2019

Rationale for Targeting Deregulated Metabolic Pathways as a Therapeutic Strategy in Acute Myeloid Leukemia.

Nicolas Chapuis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.